Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. (Q48787738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

R H Knopp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P Alagona

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Davidson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A C Goldberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S D Kafonek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Kashyap

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

D Sprecher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Jenkins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Marcovina

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1097-1104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Niacin revisited. A randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Low-dose, time-release nicotinic acid: effects in selected patients with low concentrations of high-density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Nocturnal inhibition of lipolysis in man by nicotinic acid and derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Precipitation methods for quantification of lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Substrate delivery as a determinant of hepatic apoB secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Differential effects of nicotinic acid in subjects with different LDL subclass patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Niacin and hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

Nicotinic acid-induced fulminant hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990284-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(98)90284-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9751239%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference